Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 6/20 | 0.48 |
| ▸ | SLC33A1 | O00400 | 8/20 | 0.45 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4312498 | 0.88 | PPARG (0.45) | PPARGSLC33A1AGTR1 | |
| SCHEMBL4013001 | 0.88 | PPARG (0.48) | PPARGAGTR1 | |
| SCHEMBL4016688 | 0.87 | PPARG (0.47) | PPARGAGTR1 | |
| SCHEMBL4010901 | 0.85 | PPARG (0.44) | PPARGSLC33A1AGTR1 | |
| SCHEMBL4017556 | 0.85 | PPARG (0.45) | PPARGSLC33A1AGTR1 | |
| SCHEMBL4011144 | 0.84 | SLC33A1 (0.47) | PPARGSLC33A1AGTR1 | |
| SCHEMBL4012804 | 0.83 | SLC33A1 (0.47) | PPARGSLC33A1AGTR1 | |
| SCHEMBL4012167 | 0.82 | SLC33A1 (0.45) | PPARGSLC33A1AGTR1 | |
| SCHEMBL4010722 | 0.82 | PPARG (0.45) | PPARGSLC33A1AGTR1 | |
| SCHEMBL4011449 | 0.81 | SLC33A1 (0.53) | PPARGSLC33A1AGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009133970-A1 | CRYSTALLINE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-11-05 | — | — | WO | disclosed |
| EP-2074117-A2 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008062905-A2 | HETEROMONOCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-05-29 | — | — | WO | disclosed |